Would it be so hard for our CEO or IR to reach out to these analysts and get them to take notice of our huge FDA BTD and upcoming trials? Analysts love getting a heads-up to a still-undiscovered "next big thing".
Firm |
Analyst |
Bloom Burton & Co.
|
David Martin |
Cowen
|
Marc Frahm |
Goldman Sachs
|
Paul Choi |
Morgan Stanley
|
Jeff Hung |
Northland Capital Markets
|
Tim Chiang |
Piper Sandler
|
Joe Catanzaro |